undamentalytics Newsletter
Sign in

Doximity, Inc. revenue

Doximity, Inc.'s revenue was $645m in fiscal 2026, up 13.1% on the year before. Since fiscal 2020 ($116m) it has grown at a compound 33.0% a year. Over the last twelve months it was $656m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Mar 20202021Mar 20212022Mar 20222023Mar 20232024Mar 20242025Mar 20252026Mar 2026LTMJun 2026
Revenue116207344419475570645656
Growth on the year before—+77.8%+66.0%+22.0%+13.5%+20.0%+13.1%—
Gross profit101176304366425515575577
Gross margin87.2%84.9%88.4%87.2%89.3%90.2%89.1%88.1%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to March 31, 2026
Products and services
Line of business Revenue Share YoY
Subscription $608M 94.3% ▲ 11.9%
Other services $36.5M 5.7% ▲ 36.9%

From Doximity, Inc.'s 10-K filed May 19, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Technology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Doximity, Inc. $656m 11.2% 14.5%
Goodrx Holdings, Inc. $785m -1.8% 1.8%
Phreesia, Inc. $508m 12.9% 16.7%
Genedx Holdings Corp. $454m 25.4% 24.3%
Omnicell, Inc. $1.25bn 8.5% 0.3%
Waystar Holding Corp. $1.26bn 21.4% —

Compare with peers

Head to head: DOCS vs GDRXDOCS vs PHRDOCS vs WGS

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Doximity, Inc.'s SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Doximity, Inc.